immuno-oncology - gestinad€¦ · immuno-oncology asco review 21 y 22 de septiembre de 2017 madrid...

3
W H A T ´ S C O M I N G I N IMMUNO-ONCOLOGY ASCO review 21 y 22 de septiembre de 2017 Madrid Con el aval científico de: COORDINADORES Patrocinadores Hilario Mata, PhD, MBA. Director of Global Academic Programs at the University of Texas M.D. Anderson Cancer Center. TBD

Upload: others

Post on 22-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: IMMUNO-ONCOLOGY - Gestinad€¦ · IMMUNO-ONCOLOGY ASCO review 21 y 22 de septiembre de 2017 Madrid Con el aval científico de: COORDINADORES Patrocinadores Hilario Mata, PhD, MBA

W H A T ´ S C O M I N G I N

IMMUNO-ONCOLOGYASCO review

21 y 22 de septiembre de 2017Madrid

Con el aval científico de:

COORDINADORES

Patrocinadores

Hilario Mata, PhD, MBA.Director of Global Academic

Programs at the University of TexasM.D. Anderson Cancer Center.

TBD

Page 2: IMMUNO-ONCOLOGY - Gestinad€¦ · IMMUNO-ONCOLOGY ASCO review 21 y 22 de septiembre de 2017 Madrid Con el aval científico de: COORDINADORES Patrocinadores Hilario Mata, PhD, MBA

15:30 - 16:00 CAFÉ BIENVENIDA / WELCOME COFFEE

16:00 - 16:10 BIENVENIDA / WELCOME

Moderadores - ChairpersonsTBD

16:10 - 16:40 Resumen ASCO en Cáncer Renal - ASCO Summary in Renal Cancer TBD

16:40 - 17:10 Ponencia - Speech José A. Karam, MD, FACS. Department of Urology, Division of Surgery. MD Anderson Cancer Center, Houston.

17:10 - 17:30 Pipeline Industria farmacéutica TBD

17:30 - 18:00 DEBATE / Q&A

18:00 - 18:15 CIERRE / CLOSURE

Moderadores - ChairpersonsTBD

9:00 - 9:30 Resumen ASCO en Melanoma - ASCO Summary in Melanoma TBD

9:30 - 10:10 Ponencia - Speech Michael A. Davies, MD, PhD. Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston.

10:10 - 10:30 Pipeline Industria farmacéutica TBD

10:30 - 11:00 DEBATE / Q&A

11:00 - 11:30 PAUSA CAFÉ / COFFEE BREAK

Moderadores - ChairpersonsTBD

11:30 - 12:00 Resumen ASCO en Cáncer de Mama - ASCO Summary in Breast Cancer TBD

12:00 - 12:30 Ponencia - Speech Vicente Valero, MD, F.A.C.P. Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston.

12:30 - 12:45 Pipeline Industria farmacéutica TBD

12:45 - 13:15 DEBATE / Q&A

13:15 - 14:30 PAUSA ALMUERZO / LUNCH BREAK

Moderadores - ChairpersonsTBD

14:30 - 15:00 Resumen ASCO en Cáncer de Pulmón - ASCO Summary in Lung Cancer TBD

15:00 - 15:40 Ponencia - Speech George Simon, MD, FACP, FCCP. Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston.

15:40 - 16:00 Pipeline industria farmacéutica TBD

16:00 - 16:30 DEBATE / Q&A

16:30 - 16:45 PAUSA CAFÉ / COFFEE BREAK

Moderadores - ChairpersonsTBD

16:45 - 17:15 Resumen ASCO en Cáncer Colorrectal - ASCO Summary in Colorectal Cancer TBD

17:15 - 18:00 Ponencia - Speech TBD

18:00 - 18:15 Pipeline Industria farmacéutica TBD

18:15 - 18:45 DEBATE / Q&A

18:45 - 19:00 CIERRE / CLOSURE

ASCO review

J U E V E S 2 1

V I E R N E S 2 2

16:1

0- 1

8:00

CÁN

CER

REN

AL -

REN

AL C

ANCE

R

9:00

- 11

:00

M

ELAN

OM

A14

:30

- 16:

30CÁ

NCE

R DE

PU

LMÓ

NLU

NG

CAN

CER

16:4

5 - 1

8:45

CÁN

CER

COLO

RREC

TAL

COLO

RECT

AL C

ANCE

R

11:3

0 - 1

3:15

CÁN

CER

DE M

AMA

BREA

ST C

ANCE

R

PROGRAMA

Page 3: IMMUNO-ONCOLOGY - Gestinad€¦ · IMMUNO-ONCOLOGY ASCO review 21 y 22 de septiembre de 2017 Madrid Con el aval científico de: COORDINADORES Patrocinadores Hilario Mata, PhD, MBA

José A. Karam, MD, FACS. Department of Urology, Division of Surgery. MD Anderson Cancer Center, Houston. Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Administrative Appointments/Responsibilities Member, Cancer Education Committee - Genitourinary Cancer Track, American Society of Clinical Oncology (ASCO), Alexandria, VA, 6/2013-5/2016. Ex Officio Member, AACR Clinical and Translational Research Committee, Philadelphia, PA, 2010-2012. Member, Associate Member Council, American Association of Cancer Research, Philadelphia, PA, 2008-2011.

George Simon, MD, FACP, FCCP. Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston. Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Chief, Section of Experimental Therapeutics, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

TBD

Michael A. Davies, MD, PhD. Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston. Associate Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Deputy Chair, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Co-Leader of Melanoma Moon Shot Program, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, TX. Director of Research Activities, Hematology/Oncology Fellowship Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Vicente Valero, MD, F.A.C.P. Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston. Deputy Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

ASCO review21 y 22 de septiembre de 2017

Hilario Mata, PhD, MBA.Director of Global AcademicPrograms at the University of TexasM.D. Anderson Cancer Center.

TBD

CÁNCER RENAL - RENAL CANCER

CÁNCER DE MAMA - BREAST CANCER

CÁNCER COLORRECTAL - COLORECTAL CANCER

CÁNCER DE PULMÓN - LUNG CANCER

MELANOMA

PONENTES

COORDINADORES

J U E V E S 2 1

V I E R N E S 2 2